LifeCell misses Street

Tissue repair company LIFC reported third quarter diluted EPS of $0.07, missing the Street's estimate by $0.03 but up 133% from $0.03 in the third quarter of 2004. This year's quarter includes a previously announced $1.4 million write-off of inventory for recalled products and a $469,000 reserve for product returns and associated expenses. LIFC reiterated third quarter product revenues of $24.3 million, up 62% from $14.9 million in the same period last year. ...